ASN95 -- Selected abstracts: Focal Glomerulosclerosis
Mon. Nov. 6 1995
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
clinical transplantation: Immunosuppressive treatment
Program number 1153 board# m422 at 10:00 A.M.
The impact of plasmapheresis on
recurrent focal glomerular sclerosis in renal allografts. A.
Vats, J. Basgen, M. Steffes and M. Mauer. - Minneapolis, MN.
Tue. Nov. 7 1995
9:00 A.M. ---Poster highlights--- San Diego Conv Ctr Halls A and B
glomerular diseases
Program number 1543 at na
Focal segmental glomerulosclerosis
due to cholesterol atheroembolic renal disease: Clinicopathologic
correlations. A. Iqbahl, A. Greenberg, D. Borochovitz, S.I. Bastacky
and J.P. Johnson. - Pittsburg, PA.
Program number 1545 at na
Renal survival and complete remission in steroid-Treated vs.
Untreated adult focal segmental glomerulosclerosis. J. J. Dillon. - Chicago, Il.
Program number 1546 at na
Two populations of focal segmental glomerulosclerosis in
children. S.L. Schulman, J. Vanisko and B.S. Kaplan. - Philadelphia, Pa.
Program number 1547 at na
Follow up results from a randomized controlled trial of
cyclosporine versus placebo in adults with steroid resistant idiopathic focal segmental
glomerulosclerosis. D. Cattran, C. Greenwood, L. Hebert, M. Pohl, l. Hunsicker, D.
Maxwelland C. Kunis. -
Toronto, Canada.
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
mechanisms of sclerosis
Program number 1583 board# t133 at 10:00 A.M.
Nephronopenic focal segmental glomerulosclerosis and glomerular
size. - D.B. Bhathena. - Detroit, MI.
4:00 P.M. ---Free communications--- San Diego Conv Ctr Rm 11a
pathogenesis of glomerular disease
Program number 2129 at 5:00
Wt1 immunoreactivity in normal and pathologic human
kidney biopsies. J. Ph. Rougier, E. Fischer, J.M. Morris, M.C. Verpont, F.J. Rauscher III
and
P.M. Ronco. - Paris, France and Philadelphia, Pa.
Use BACK arrow on your browser (faster) or click
here to go back to ASN95 main page
Click
on ARROW for HDCN Home Page.